Effect of ascorbate on covalent binding of benzene and phenol metabolites to isolated tissue preparations by Smart, Robert C. & Zannoni, Vincent G.
TOXICOLOGY AND APPLIED PHARMACOLOGY 77, 334-343 (1985) 
Effect of Ascorbate on Covalent Binding of Benzene and Phenol 
Metabolites to Isolated Tissue Preparations’ 
ROBERT C. SMART AND VINCENT G. ZANNONI 
Department of Pharmacology and Department of Environmental and Industrial Health, Toxicology Program, 
University of Michigan, Ann Arbor, Michigan 48109 
Received June 7, 1984; accepted October I, 1984 
Effect of Ascotbate on Covalent Binding of Benzene and Phenol Metabohtes to Isolated 
Tissue Preparations. SMART, R. C. and ZANNONI, V. G. (1985). Toxicol. Appl. Pharmacol. 77, 
334-343. [‘4C]Phenol and [‘4C]benzene are metabolized in the presence of NADPH and hepatic 
microsomes isolated from phenobarbital- or benzene-pretreated or untreated guinea pigs to 
intermediates capable of covalently binding to microsomal protein. When 1 mM ascorbate was 
included in the incubation mixture containing benzene as the substrate, covalent binding was 
inhibited by 55%. Increasing the ascorbate concentration to 5 mM inhibited binding by only 
an additional 17%. In contrast, when phenol was used as the substrate, 1 mM ascorbate 
inhibited binding by 95%. When DTdiaphorase was included in the incubation mixture 
containing benzene as the substrate, binding was inhibited by only 18%. This degree of 
inhibition is in contrast to 70% inhibition with phenol. These results indicate that different 
metabolites are responsible for a portion of the covalent binding depending upon the substrate 
employed. GSH inhibited covalent binding greater than 95% with either substrate. The 
metabolism of phenol to hydroquinone was unaffected by the addition of ascorbate or GSH. 
The metabolism of benzene to phenol was unaffected by the addition of GSH; however. the 
addition of ascorbate decreased the formation of phenol by 35%. Tissue ascorbate could be 
modulated by placing guinea pigs on different dietary intakes of ascorbate. Bone marrow 
ascorbate concentrations could be modulated IO-fold without any significant change in the 
GSH concentrations. Bone marrow isolated from guinea pigs on different dietary intakes of 
ascorbate were incubated with Hz01 and phenol. Bone marrow with low ascorbate concentrations 
displayed 4-fold more covalent binding of phenol equivalents than those with high ascorbate 
concentrations. This is an example of how the dietary intake of ascorbate can result in a 
differential response to a pOtentially toxic event in Vitro. Q 1985 Academsc press. Inc. 
It has been established for many years that 
the bone marrow is the target site of benzene 
toxicity. Chronic exposure to benzene results 
in hemopoietic disorders such as aplastic 
anemia (Snyder and Kocsis, 1975; Snyder et 
al., 1981). In addition, the relationship be- 
tween benzene exposure and the development 
of acute myelogenous leukemia in humans 
has been established (IARC, 1982). It is 
generally accepted that benzene must undergo 
’ This work was supported by Grant 23007 from 
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metabolic activation to produce its toxicity 
(Andrews et al., 1977; Bolcsak and Nerland, 
1983; Nomiyama, 1962; Sammett et al., 
1979). Phenol, hydroquinone, and catechol 
are the major metabolites of benzene (Por- 
teous and Williams, 1949); however, the me- 
tabolite responsible for benzene’s myelotox- 
icity is unknown. Covalent binding of reactive 
intermediates has been reported to be in- 
volved in the toxicity or carcinogenicity of a 
number of xenobiotics (Jollow et al., 1973; 
Jollow et al., 1974; Miller and Miller, 197 1). 
The activation of benzene metabolites with 
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subsequent covalent binding to bone marrow 
constituents could result in the toxic event. 
Tunek et al. (1978) have postulated that a 
further metabolite of phenol is responsible 
for the majority of covalent binding when 
benzene or phenol is incubated with rat 
hepatic microsomes. We have previously 
demonstrated that the majority of covalent 
binding occurring during the metabolism of 
phenol is due to the oxidized forms of hy- 
droquinone and catechol (Smart and Zan- 
noni, 1984). We have employed an in vitro 
system using guinea pig hepatic microsomes, 
NADPH, and benzene or phenol to determine 
if the metabolites that covalently bind are 
the same with either substrate. This deter- 
mination was accomplished by comparing 
the degree in which various agents or enzymes 
could inhibit covalent binding of the metab- 
olites of phenol vs the metabolites of benzene. 
Guinea pigs have been reported to be 
susceptible to the myelotoxic effects of ben- 
zene as determined by decreases in circulating 
blood cells (Das et al., 1969; Wolf et al., 
1956). Studies in a variety of laboratories 
have demonstrated that ascorbate is capable 
of preventing covalent binding of numerous 
reactive intermediates (Corcoran et al., 1980; 
Sawahata and Neal, 1983; Smart and Zan- 
noni, 1984). Agents which can prevent co- 
valent binding are of interest since they may 
alter toxicity in vivo. The present study also 
explores the effect of endogenous tissue as- 
corbate in preventing the in vitro covalent 
binding of phenol equivalents using bone 
marrow preparations isolated from pair-fed 
guinea pigs on different dietary intakes of 
ascorbate. Since the guinea pig is similar to 
man in that it cannot synthesize this vitamin, 
it is an excellent model to modulate the 
ascorbate concentration in a variety of tissues 
by controlling the diet. 
METHODS 
Chemicals. Phenol and dicumarol were purchased 
from Aldrich Chemical Company, (Milwaukee, Wise.), 
[‘4C]Phenol (8.3 mCi/mmol) and [“C]benzene (57.4 
mCi/mmol) were purchased from New England Nuclear 
Corporation (Boston, Mass.). Specific activity of phenol 
was adjusted to 0.16 mCi/mmol and benzene to 0.4 
mCi/mmol. [i4C]Phenol was extracted from the benzene 
solution as previously described (Smart and Zannoni, 
1984). The radiochemical purity of both phenol and 
benzene was >98%. Sodium ascorbate was purchased 
from Sigma Chemical Company (St. Louis, MO.). Re- 
duced glutathione, 3% hydrogen peroxide, benzene, and 
01, o’dipyridyl were purchased from Fisher Scientific 
Company (Fair Lawn, N.J.). ACS scintillation mixture 
was purchased from Amersham (Arlington Heights, III.). 
Dietary ascorbate regimens. Three groups of five to 
six male Hartley guinea pigs (200 to 250 g, Michigan 
State Department of Health, East Lansing, Mich.) were 
placed on three different dietary intakes of ascorbate; 
1.0, 0.35, and 0.05 mg ascorbate/ml drinking water for 
4 weeks. All groups received ascorbatedeticient guinea 
pig chow ad libitum (ICN Nutritional Biochemicab, 
Cleveland, Ohio) and were housed at 22 f  2°C on a 12- 
hr light cycle. The growth curves for the duration of the 
feeding were similar for the three groups. The group 
receiving the lowest amount of ascorbate, 0.05 mg/ml in 
their drinking water, showed no signs of ascorbate defi- 
ciency, i.e., hemorrhages or weight loss. It can be estimated 
that the guinea pigs in this group consumed at least 1.5 
mg ascorbate animal-’ day-‘. These three groups were 
used for the quantitation of ascorbate and GSH in the 
lungs, liver, and bone marrow. Tissue ascorbate was 
measured by the method of Zannoni et al. (1974). GSH 
was measured by the method of Ellman (1959). Another 
group of guinea pigs was pair-fed and their bone marrow 
was isolated from individual femurs, which was then 
used in binding studies with phenol and hydrogen per- 
oxide. Pair-feeding was carried out with ascorbate deficient 
guinea pig chow for 18 days using two groups of five 
guinea pigs. One group received 0.5 mg ascorbate/ml 
drinking water, the other received no ascorbate. The 
bone marrow was isolated from both femurs of each 
animal, and homogenized individually in 10 vol of 100 
mM sodium phosphate buffer, pH 7.4. Peroxidase activity 
was measured with guaiacol (Smart and Zannoni, 1984). 
Guinea pig pretreatment and preparation of hepatic 
microsomes. Male Hartley guinea pigs (250 to 350 g) 
were treated with 1 mg of phenobarbital/ml in the 
drinking water for 5 days or 1. I g/kg benzene ip in an 
equal volume of corn oil twice, 18 and 24 hr before 
termination. This dose of benzene was used since it 
effectively induced benzene metabolism in Sprague- 
Dawley rats (Post and Snyder, 1983). Animals were 
decapitated, and their livers were removed and placed 
on ice and homogenized in 4 vol 100 mM sodium 
phosphate buffer, pH 7.4. The homogenates were centri- 
fuged at 15,OOOg for 20 min, and the postmitochondrial 
supematant fraction was centrifuged at 100,OOOg for 1 
hr to harvest the microsomes. The microsomes were 
concentrated four times (16 to 20 mg protein/ml) based 
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on initial volume of the supematant fraction. Frozen 
microsomes stored at -20°C for 3 months maintained 
activity as determined by the degree of covalent binding 
of phenol or benzene in the presence of NADPH. Prior 
to use microsomes were washed with 4 vol buffer, 
homogenized, and centrifuged at 100,000 g for 30 min. 
The supematant fraction was decanted. and the pellet 
was brought to 6 to 7 mg protein/ml. Protein was 
determined by the method of Lowry et al. (1951), with 
bovine serum albumin as standard. 
Incubation conditions and assay of covalent binding. 
The incubation mixture consisted of washed microsomes 
(0.7 to 1.2 mg protein/ml), 1 mM [‘4C]phenol or 1 mM 
[“‘Clbenzene, 1 mrvt NADPH, and 100 mM sodium 
phosphate buffer, pH 7.4. The total incubation volume 
was 1 ml. The incubation was carried out for 10 or 15 
min at 37°C in a Dubnoff shaker at 60 oscillations/min. 
Incubation conditions using isolated bone marrow prep- 
arations were as follows; 35 mg bone marrow tissue in 
100 mM sodium phosphate buffer, pH 7.4, was incubated 
with 1 mM [“Clphenol, 8.8 mM hydrogen peroxide, and 
0.7 mg microsomal protein. The total incubation volume 
was 1 ml. The incubation was for 5 min at 37°C. 
Covalent binding was measured by the method of Tunek 
et al. (1978). The method involves repeated extraction 
with ethyl acetate followed by precipitation of the protein 
with ethanol. The protein pellet was washed with an 
acetone/heptane mixture, and then methanol. The protein 
pellet was dissolved in sodium hydroxide, heated at 80°C 
for 30 min, and neutralized with HCI, and an aliquot 
was added to the scintillation mixture and counted. 
When DT-diaphorase was added to the binding assay, I 
f.cM FAD was added to optimize activity (Benson et af., 
1980; Smart and Zannoni, 1984). DT-Diaphorase was 
purified from guinea pig liver as previously described 
(Smart and Zannoni, 1984). 
Quantification of hydroquinone and phenol. The major 
product of phenol metabolism, hydroquinone, and the 
major product of benzene metabolism, phenol, were 
extracted from the incubation mixtures, quantified, and 
identified by gas chromatographic analyses with authentic 
standards. Incubation conditions were as described in 
the previous section, except that the benzene concentration 
was increased to 10 mM because quantification of the 
metabolites at I mM benzene was not possible. The 
reactions were stopped at various times with ice-cold 
ethyl acetate and placed on ice. 4-Chlororesorcinol ( 12.5 
pg) was added to each tube as an internal standard. The 
samples were centrifuged at 3000g for 5 mitt, and the 
ethyl acetate fraction was collected. This procedure was 
repeated three times with I ml ethyl acetate. Ethyl 
acetate was evaporated down to 0.2 ml at room temper- 
ature with a gentle stream of nitrogen. Twenty microliters 
acetic anhydride, 20 ~1 pyridine, and 2.5 ml ethyl ether 
were added, and the samples were derivatized at 70°C 
for I hr or until all the ethyl ether had evaporated and 
only 0.2 ml ethyl acetate remained. Samples were cooled 
to room temperature, 0.2 ml 0.5 N NaOH was added to 
remove excess reagent, the samples were centrifuged, 
and the aqueous layer was removed. The ethyl acetate 
phase was washed with 0.2 ml pentane and 0.2 ml 
distilled water, and centrifuged at 3000g for 5 min; I ~1 
was injected into a Varian 3700 gas chromatograph 
equipped with a flame ionization detector. The column 
was packed with 1% SP- 1240-DA on 100,’ 120 Supelco- 
port; the column dimensions were 2 m X 2 mm, and 
was purchased from Supclco. The injector temperature 
was 220°C; column, 157°C: and detector, 250°C; the 
flow rate was 40 ml/min. For quantification of phenol 
formation from benzene, the flow rate was decreased to 
15 ml/min and the column temperature was decreased 
to 120°C: after the phenol peak, the column temperature 
was increased to 180°C to hasten the elution of the 
standard. Standard curves were obtained and plotted as 
the peak height ratios, hydroquinone/4-chlororesorcinol 
and phenol/4chlororesorcinol. The ratio of hydroquinone 
formed from phenol and the ratio of phenol formed 
from benzene to the standard, 4-chlororesorcinol, pro- 
vided a direct index of the amount of product formed 
from the enzymatic incubation of phenol or benzene 
and NADPH. When NADPH was omitted from this 
incubation mixture, hydroquinone or phenol could not 
be detected in the respective incubation mixtures. 
Statistical analyses. Statistical analyses were conducted 
by the Student t-test. The level of statistical significance 
used wasp < 0.01. 
RESULTS 
Comparison of the Efect of Ascorbate, GSH, 
and DT-Diaphorase on the Metabolism 
and Covalent Binding Using either Benzene 
or Phenol as Substrates 
Both [‘4C]benzene and [‘4C]phenol are 
metabolized in the presence of NADPH and 
hepatic microsomes isolated from phenobar- 
bital-pretreated guinea pigs to intermediates 
capable of covalently binding to microsomal 
protein in vitro (Table 1). The quantity of 
covalent binding and metabolite formation 
was linear for at least 15 min and proportional 
to protein concentration. NADPH was re- 
quired for covalent binding; without it less 
than 5% of the binding occurred. Ascorbate 
and glutathione were capable of significantly 
inhibiting covalent binding (Table 1). As 
shown in Fig. 1, when [14C]benzene was 
incubated with hepatic microsomes isolated 
from benzene-pretreated or untreated guinea 
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TABLE 1 
EFFECT OF ASCORBATE AND GLUTATHIONE ON Co- 
VALENT BINDING OF [14C]~~~~~ OR ['%]BENZENE ME- 
TABOLITES TO HEPATIC MICROSOMAL PROTEIN IN VITRO 
Covalent binding 
(pmol phenol or 
benzene equivalents 
bound 10 min-’ mg 
Additions microsomal protein-‘)” 
With [‘%]benzene 
None (control with 
NADPH) 1044 + 188 (3)b 
Ascorbate (1 mM) 299 f  34 (3) 
Glutathione ( 1 mM) 33 k 22 (3) 
With [‘4C]phenol 
None (control with 
NADPH) 2527 + 123 (4) 
Ascorbate (1 mM) 134 + 17 (4) 
Glutathione ( 1 mM) 10 f  19 (4) 
Note. [‘4C]Phenol (1 mM) or [i4C]benzene (1 mM) were 
incubated with 0.7 to 1 mg of washed hepatic microsomal 
protein isolated from phenobarbital-pretreated guinea pigs, 
NADPH (1 mM), and sodium phosphate buffer (100 mtvr, 
pH 7.4). The incubation was carried out for 10 or 15 min 
at 37°C. The total volume was 1 ml. 
(1 Values are expressed as X + SD. 
b The number in parentheses equals the number of ex- 
periments done in duplicate. 
pigs, ascorbate and glutathione were also 
capable of inhibiting covalent binding. The 
amount of covalent binding was significantly 
greater when microsomes isolated from phe- 
nobarbital- or benzene-pretreated guinea pigs 
were used as compared to microsomes from 
untreated guinea pigs. However, the amount 
of binding in the presence of ascorbate or 
GSH was not significantly different regardless 
of pretreatment when compared to that when 
microsomes from untreated guinea pigs were 
used (Fig. 1). The effect of increasing the 
concentration of ascorbate on binding is 
shown in Fig. 2. At a concentration of 1 mM 
ascorbate covalent binding was inhibited by 
55%, while at a concentration of 5 mM 
binding was only decmased an additional 17%. 
A comparison of the effect of various 






FIG. 1. Inhibition of covalent binding of benzene 
metabolites by ascorbate or GSH with hepatic microsomes 
isolated from normal, or benzene-, or phenobarbital- 
pretreated guinea pigs. [i4C]Benzene (1 mM) was incu- 
bated with 0.7 to 1 .O mg of washed hepatic microsomal 
protein isolated from untreated, or benzene- or pheno- 
barbital-pretreated guinea pigs, NADPH (1 mM) and 
sodium phosphate buffer (100 mM, pH 7.4). The incu- 
bation was carried out for 15 min at 37°C. The total 
volume was 1 ml. q NADPH; n NADPH + 1 mM 
ascorbate; RJ NADPH + 1 mM GSH. The pretreatment 
of animals is given under Methods. Each value represents 
the mean of three experiments done in duplicate + SD. 
or [‘4C]phenol is shown in Figs. 3a and b. 
We have previously shown that DTdiapho- 
rase can inhibit covalent binding when phenol 
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FIG. 2. Effect of varying concentrations of ascorbate 
on covalent binding of benzene metabolites with micro- 
somes isolated from benzene-pretreated guinea pigs. 
[i4C]Benzene (1 mM) was incubated under conditions 
given in Fig. 1. In addition, the incubation was carried 
out with various concentrations of ascorbate indicated 
in the figure. 
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crosomes by reducing the metabolites of phe- 
nol, o- and p-benzoquinone (Smart and Zan- 
noni, 1984). When DT-diaphorase was in- 
cluded in the incubation mixture containing 
[14C]benzene as the substrate, covalent bind- 
ing was decreased by only 18% (Fig. 3a). In 
contrast, when DT-diaphorase was included 
in the incubation mixture containing [14C]- 
phenol, covalent binding was decreased by 
70% (Fig. 3b). The effect of DT-diaphorase 
could be reversed with the inclusion of 10 
PM dicumarol, a specific inhibitor of DT- 
diaphorase. When 1 mM ascorbate was in- 
cluded in the incubation mixture containing 
[ 14C]benzene or [ “C]phenol, binding was 
inhibited by 55 and 95%, respectively (Figs. 
3a and b). On the other hand, GSH was 
effective in inhibiting covalent binding greater 
than 95% with either substrate (Figs. 3a 
and b). 
As shown in Table 2, the inclusion of 1 
mM ascorbate or GSH had no significant 
effect on the MFO metabolism of phenol to 
its major metabolite, hydroquinone. How- 
ever, ascorbate decreased the formation of 
phenol from benzene by 35%, while GSH 
did not effect the formation of phenol from 
benzene. 
Modulation of Ascorbate Tissue Concentra- 
tions In Vivo and the Determination of 
Covalent Binding of Phenol in Isolated 
Bone Marrow Preparations 
Since ascorbate was effective in inhibiting 
covalent binding with phenol or benzene, it 
was of interest to determine if the endogenous 
tissue concentrations of ascorbate could affect 
covalent binding in isolated bone marrow 
preparations from guinea pigs on various 
intakes of dietary ascorbate. To modulate the 
ascorbate tissue concentrations in vivo, three 
groups of guinea pigs were fed an ascorbate- 
free chow diet and various amounts of as- 
corbate were added to the drinking water. 
Guinea pigs were terminated after 4 weeks, 
and ascorbate and GSH concentrations were 
determined in lung, liver, and bone marrow 
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FIG. 3. (a) Effect of DT-diaphorase, ascorbate, or GSH on covalent binding of benzene metabolites 
with microsomes isolated from benzene-pretreated guinea pigs. [14C]Benzene (1 mM) was incubated under 
conditions given in Fig. 1. In addition, the incubation contained 2 units DTdiaphorase, ascorbate (1 
mM), or GSH (1 mM). One unit of DTdiaphorase is defined as 1 Frnol pbenzoquinone reduced/min. 
Each value represents the mean of three experiments done in duplicate of: SD. (b) Effect of DT-diaphorase, 
ascorbate, or GSH on covalent binding of phenol metabolites with microsomes isolated from phenobarbital- 
pretreated guinea pigs. [ ‘%]Phenol (1 mM) was incubated under conditions given in Fig. 1. The incubation 
time was 10 min. In addition, the incubation contained 2 units DTdiaphorase, ascorbate (1 mM), or 
GSH (1 mM). One unit of DTdiaphorase is defined as 1 pmol pbenzoquinone reduced/min. Each value 
represents the mean of three experiments done in duplicate + SD. 
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TABLE 2 
EFFE~ OF ASCORBATE AND GLUTATHIONE ON THE 
METABOLISM OF PHENOL OR BENZENE BY HEPATIC MI- 
CROSOMES 
Additions 
nmol Phenol formed min-’ 
mg microsomal protein-’ ” 
With benzene 
None (control with 
NADPH) 
Ascorbate (I mM) 
Glutathione (1 mM) 
2.87 + 0.15 
1.85 f 0.08’ 
2.57 + 0.19 
nmol hydroquinone formed min-’ 
mg microsomal protein-’ 0 
With phenol 
None (control with 
NADPH) 
Ascorbate (I mM) 
Glutathione (I mM) 
2.50 -c 0.32 
2.74 k 0.08 
2.40 z!z 0.2 1 
No@. Phenol (I mM) or benzene (IO mht) were incubated with 
1.2 mg of washed hepatic microsomal protein from phenobarbital- 
pretreated guinea pigs, NADPH (I mM), and sodium phosphate 
buffer ( 100 mht, pH 7.4). The incubation was carried out for 15 
min at 37°C. The total volume was 1 ml. 
a Each experiment was done three timeq and values are expressed 
as X k SD. 
b Significantly different from the control (p i 0.01). 
target site of benzene toxicity, the ascorbate 
tissue concentration could be modulated in 
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FIG. 4. Ascorbate concentration in liver, lung, and 
bone marrow in guinea pigs on various dietary regimens 
of ascorbate. Three groups of guinea pigs were fed 
varying amounts of ascorbate in their drinking water, as 
indicated in the figure. fR liver; n lung; iB bone marrow. 
All groups received ascorbate-free guinea pig chow for 4 
weeks. Tissue concentrations were determined for each 
individual animal; the data represent X + SD. 
1.0 q/ml 0.35 mg/ml 0.05 mg/d 
mg  ascotih/d of tit-king wahr 
FIG. 5. GSH concentration in liver, lung, and bone 
marrow in guinea pigs on various dietary regimens of 
ascorbate. Three groups of guinea pigs were fed varying 
amounts of ascorbate in their drinking water, as indicated 
in the figure. q liver; n lung; 0 bone marrow. All groups 
received ascorbate-free guinea pig chow for 4 weeks. 
Tissue concentrations were determined for each individual 
animal: the data represent X + SD. 
concentration was not significantly altered 
(Fig. 5). 
We have previously shown that a red 
blood cell-free myeloperoxidase preparation 
from guinea pig bone marrow in the presence 
of hydrogen peroxide is capable of metabo- 
lizing phenol to intermediates which cova- 
lently bind to protein, and that this binding 
is inhibited greater than 95% with 1 BIM 
ascorbate (Smart and Zannoni, 1984). In the 
present study we have used [14C]phenol as a 
model hydroxylated metabolite of benzene 
to determine if bone marrow isolated from 
guinea pigs on different dietary intakes of 
ascorbate could differentially alter covalent 
binding of phenol equivalents to protein. 
Bone marrow was isolated and homogenates 
were prepared from two groups of guinea 
pigs which were pair-fed for 18 days on 
ascorbate-free chow; one group received 0.5 
mg ascorbate/ml drinking water; while the 
other group did not receive any ascorbate. 
There was no significant difference in myelo- 
peroxidase activity between the two groups. 
Oxidation of phenol or guaiacol by these 
bone marrow homogenates required hydrogen 
peroxide. Bone marrow homogenates from 
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each guinea pig were incubated with 
[‘4C]phenol and 8.8 BIM HzOz, and subse- 
quent covalent binding of phenol equivalents 
to protein was quantitated. Covalent binding 
occurred only if hydrogen peroxide was in- 
cluded in the incubation mixture. As shown 
in Table 3, covalent binding of phenol equiv- 
alents in bone marrow homogenates isolated 
from guinea pigs on the ascorbate-free diet 
was 4-fold higher than bone marrow homog- 
enates isolated from the group receiving 0.5 
mg ascorbate/ml drinking water. By compar- 
ing the hepatic ascorbate concentrations of 
each group (Table 3), it can be determined 
from Fig. 4 that the bone marrow ascorbate 
concentrations were on the order of IO-fold 
higher in the group receiving 0.5 mg ascor- 
bate/ml drinking water. As shown in Fig. 5, 
there was very little change in GSH concen- 
trations in the bone marrow or liver of 
guinea pigs on different intakes of ascorbate. 
[‘4C]Benzene was incubated under the 
same conditions as phenol, and subsequent 
covalent binding was measured. Covalent 
binding of benzene equivalents to bone mar- 
row protein was equal to or slightly above 
background binding. This amount of covalent 
binding using bone marrow preparations with 
an endogenous low ascorbate concentration 
was 72.4 f 33.4 pmol covalently bound/5 
min, only 2.3% of that when phenol was 
used. 
DISCUSSION 
We have shown that, when [14Clbenzene 
or [‘4C]phenol are incubated with isolated 
hepatic microsomes and NADPH, GSH, as- 
corbate, or DT-diaphorase are capable of 
decreasing covalent binding of the metabolites 
generated in vitro. Importantly, we have 
found that the two substrates, benzene and 
phenol, differ substantially with regard to the 
ability of ascorbate and DT-diaphorase to 
inhibit covalent binding of their metabolites. 
It appears that the metabolites which are 
binding are different depending upon whether 
phenol or benzene is used as the substrate. 
We have shown previously that, when phenol 
is incubated with NADPH and isolated he- 
patic microsomes, DT-diaphorase decreases 
covalent binding by 70% by reducing o- and 
p-benzoquinone (Smart and Zannoni, 1984). 
Ascorbate inhibits covalent binding of the 
metabolites of phenol by 95% and ascorbate 
reduces electrophilic quinone species (Cor- 
coran et al., 1980; La Du and Zannoni, 
1963). Phenol metabolism, as determined by 
the formation of hydroquinone, was unaf- 
fected by the inclusion of 1 mM ascorbate, 
indicating that the decrease in covalent bind- 
ing is due to the reducing ability of ascorbate. 
GSH inhibited covalent binding of the me- 
tabolites of phenol by >95%, and also had 
no effect on the metabolism of phenol. This 
TABLE 3 
EFFECT OF DIETARY A~CORBATE ON COVALENT BINDING OF [14C]~~~~~ WITH ISOLATED 
BONE MARROW PREPARATIONS FROM PAIR-FED GUINEA PIG@ 
Diet 
pmol Phenol mg% 
equivalents covalently Ascorbate 
bound/5 mitt’ (hepatic)’ 
0.5 mg ascorbatelml of drinking water; ascorbate-free 
guinea pig chow 
0.0 mg ascorbate/ml of drinking water; ascorbate-free 
guinea pig chow 
882.3 + 105.5 34.1 f 17.9 
3108.7 f 159.2 3.1 + 1.6 
a n = 5 individual guinea pigs/group. 
b All incubation contained [r4C]phenol (1 mh@, sodium phosphate buffer (1 mM, pH 7.4), H202 (8.8 mM), 35 mg 
bone marrow tissue, and 0.7 mg microsomal protein. 
’ Values are expressed as the means of five individual values f SD. 
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information indicates that the decrease in 
binding is due to the interaction of GSH 
with the reactive metabolite(s). 
On the other hand, covalent binding oc- 
curring during the metabolism of 1 mM 
benzene in the presence of ascorbate is de- 
creased from 47 to 7 1% depending on if 
microsomes isolated from untreated, benzene- 
pretreated, or phenobarbital-pretreated guinea 
pigs were used. In fact, the addition of 5 mM 
ascorbate only inhibited covalent binding an 
additional 17% when microsomes from ben- 
zene-pretreated guinea pigs were used. In 
contrast to phenol metabolism, the metabo- 
lism of benzene was inhibited 35% by ascor- 
bate as determined by phenol formation when 
incubated with NADPH, 10 mM benzene, 
and microsomes isolated form phenobarbital- 
pretreated guinea pigs. Assuming that ascor- 
bate is also inhibiting the metabolism of 
benzene by 35% when microsomes from 
untreated or benzene-pretreated guinea pigs 
are used, the contribution of ascorbate as a 
reducing agent would range between 17 and 
36%. Even if ascorbate had no effect on the 
metabolism of benzene, there is still a twofold 
difference between the reducing ability of 
ascorbate to decrease covalent binding with 
the metabolites of phenol as opposed to those 
of benzene. When DT-diaphorase was in- 
cluded in the incubation mixture containing 
benzene as the substrate covalent binding 
was decreased by only 18%. 
Our results on the effect of ascorbate and 
DT-diaphorase indicate that the metabolite(s) 
responsible for a portion of covalent binding 
when benzene is incubated with guinea pig 
hepatic microsomes is different than that 
with phenol. An alternative explanation for 
this effect could be the differential ability of 
ascorbate or DT-diaphorase to have access 
to the reactive metabolite. The large portion 
of covalent binding occurring during the 
metabolism of benzene appears to be due to 
an intermediate prior to the formation of 
phenol. Tunek et al. (1978) found that GSH 
inhibited covalent binding when benzene or 
phenol were incubated with rat liver micro- 
somes. They postulated that a further metab- 
olite of phenol was responsible for the ob- 
served binding when benzene or phenol was 
used as the substrate. In agreement with 
Tunek et al. (1978), GSH inhibited binding 
greater than 95% with either substrate, and 
it therefore appears to be a less selective than 
ascorbate. 
Recently, Johansson and Ingelman-Sund- 
berg (1983) have suggested that the covalent 
binding occurring during the metabolism of 
benzene is due to the hydroxyl radical-me- 
diated attack of benzene with subsequent 
covalent binding of the hydroxycyclohexadi- 
enyl radical. This metabolite is formed prior 
to phenol and may be, among others, a 
candidate in our system. However, the inter- 
mediate remains to be elucidated. The sig- 
nificance of this intermediate with regard to 
myelotoxicity would depend upon the extent 
of benzene metabolism occurring in the bone 
marrow. The bone marrow has been reported 
to contain a small amount of P-450 system 
(Andrews et al., 1979). Irons et al. (1980) 
have shown that metabolism of the parent 
compound, benzene, does occur in the bone 
marrow, but only to a limited extent. The 
contribution of bone marrow MFO metabo- 
lism of benzene to myelotoxicity of benzene 
remains to be determined. 
The bone marrow is the target site of 
benzene toxicity, and much experimental 
evidence indicates that the majority of ben- 
zene is metabolized by the MFO system in 
the liver (Andrews et al., 1977; Sammett et 
al., 1979) and that subsequent metabolites 
enter the blood stream and accumulate in 
the bone marrow (Greenlee et al., 198 1; 
Rickert et al., 1979). It is also generally 
accepted that benzene requires metabolic ac- 
tivation to produce its toxicity (Andrews et 
al., 1977; Bolcsak and Nerland, 1983; No- 
miyama, 1962; Sammett et al., 1979). Sa- 
wahata and Neal (1983) have demonstrated 
that phenol is oxidized by peroxidases in the 
presence of hydrogen peroxide to intermedi- 
ates which covalentiy bind, and that o’,o- 
and p’,p-biphenol are the major products of 
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this reaction. We have demonstrated that the 
oxidation of phenol by isolated myeloperox- 
idase with subsequent covalent binding is 
blocked greater than 95% by 1 tnM ascorbate 
(Smart and Zannoni, 1984). Since we have 
demonstrated that ascorbate is generally ef- 
fective in preventing covalent binding of the 
metabolites of benzene or phenol, we have 
determined its effect on covalent binding 
using bone marrow isolated from guinea pigs 
on various dietary intakes of ascorbate. 
We have presently used phenol as a model 
hydroxylated metabolite of benzene and have 
demonstrated a fourfold increase in covalent 
binding when [r4C]phenol was incubated with 
hydrogen peroxide and bone marrow ho- 
mogenates from guinea pigs with a low as- 
corbate tissue concentration. Since ascorbate 
can block the oxidation of phenol and hy- 
drogen peroxide is required for the activation 
of phenol and for covalent binding, a bone 
marrow peroxidase (myeloperoxidase) is sus- 
peced as the enzyme responsible for the 
activation of phenol. Several studies have 
correlated benzene toxicity with the degree 
of covalent binding in the bone marrow 
(Longacre et al., 1981; Sammett et al., 1979). 
The increase in covalent binding in isolated 
bone marrow preparations with an endoge- 
nous low concentration of ascorbate is an 
example of a nutritional influence on a po- 
tentially toxic event. 
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